• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真菌耐药性的未来研究重点。

Future Research Priorities in Fungal Resistance.

机构信息

Division of General Internal Medicine.

University Hospital of South Manchester, University of Manchester, Manchester Academic Health Science Centre, United Kingdom.

出版信息

J Infect Dis. 2017 Aug 15;216(suppl_3):S484-S492. doi: 10.1093/infdis/jix103.

DOI:10.1093/infdis/jix103
PMID:28911040
Abstract

Improved understanding of basic mycological, pharmacological, and immunological processes has led to important advances in the diagnosis and treatment of invasive fungal infections. However, the rise of fungi that are resistant to existing antifungal agents poses a substantial threat to human health. Addressing this expanding problem is an urgent priority for the international research community. In this article, we highlight important diagnostic and therapeutic advances that address the rise of resistant fungi as well as new public health initiatives that warrant further investigation to help curb the spread of these potentially lethal organisms.

摘要

对基础真菌学、药理学和免疫学过程的深入了解,推动了侵袭性真菌感染的诊断和治疗方面的重要进展。然而,现有抗真菌药物耐药真菌的出现,对人类健康构成了重大威胁。解决这一日益严重的问题,是国际研究界的当务之急。本文重点介绍了一些重要的诊断和治疗进展,这些进展针对耐药真菌的出现,以及一些新的公共卫生措施,这些措施值得进一步研究,以帮助遏制这些潜在致命生物的传播。

相似文献

1
Future Research Priorities in Fungal Resistance.真菌耐药性的未来研究重点。
J Infect Dis. 2017 Aug 15;216(suppl_3):S484-S492. doi: 10.1093/infdis/jix103.
2
Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi.新型药物制剂与药物靶点应对耐药真菌挑战
J Infect Dis. 2017 Aug 15;216(suppl_3):S474-S483. doi: 10.1093/infdis/jix130.
3
Therapy for fungal diseases: opportunities and priorities.真菌病的治疗:机遇与重点。
Trends Microbiol. 2010 May;18(5):195-204. doi: 10.1016/j.tim.2010.02.004. Epub 2010 Mar 6.
4
Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.人类致病酵母和丝状真菌的耐药性:流行情况、潜在分子机制以及与人类和环境中抗真菌药物使用的关联
Dan Med J. 2016 Oct;63(10).
5
Mitigation of human-pathogenic fungi that exhibit resistance to medical agents: can clinical antifungal stewardship help?减轻对药物产生耐药性的人类致病真菌:临床抗真菌管理能有所帮助吗?
Future Microbiol. 2014;9(3):307-25. doi: 10.2217/fmb.13.160.
6
Therapeutic jackpots lie within the reach of multiscale and integrated mycological research.治疗学上的巨额奖金就在多尺度和综合真菌学研究的范围之内。
Expert Rev Anti Infect Ther. 2010 Dec;8(12):1333-5. doi: 10.1586/eri.10.113.
7
Medically important fungi respond to azole drugs: an update.具有医学重要性的真菌对唑类药物的反应:最新进展
Future Microbiol. 2015;10(8):1355-73. doi: 10.2217/FMB.15.47. Epub 2015 Aug 3.
8
Outwitting multidrug resistance to antifungals.智取抗真菌药物的多重耐药性。
Science. 2008 Jul 18;321(5887):367-9. doi: 10.1126/science.1159746.
9
Resistance to antifungal agents.对抗真菌药物的耐药性。
Pediatr Clin North Am. 1995 Jun;42(3):665-85. doi: 10.1016/s0031-3955(16)38984-2.
10
Programmed cell death in human pathogenic fungi - a possible therapeutic target.人类病原真菌中的程序性细胞死亡 - 一个可能的治疗靶点。
Expert Opin Ther Targets. 2018 Dec;22(12):1039-1048. doi: 10.1080/14728222.2018.1541087. Epub 2018 Oct 30.

引用本文的文献

1
Unveiling the menace: a thorough review of potential pandemic fungal disease.揭示威胁:对潜在大流行性真菌病的全面综述
Front Fungal Biol. 2024 Apr 22;5:1338726. doi: 10.3389/ffunb.2024.1338726. eCollection 2024.
2
A chloroacetamide derivative as a potent candidate for fusariosis treatment.一种氯乙酰胺衍生物,有望成为治疗镰孢菌病的候选药物。
Braz J Microbiol. 2022 Sep;53(3):1289-1295. doi: 10.1007/s42770-022-00771-9. Epub 2022 Jun 1.
3
Pharmacokinetics and Pharmacodynamics of Ibrexafungerp.伊巴立康唑的药代动力学和药效学。
Drugs R D. 2022 Mar;22(1):9-13. doi: 10.1007/s40268-021-00376-x. Epub 2021 Dec 27.
4
Collateral consequences of agricultural fungicides on pathogenic yeasts: A One Health perspective to tackle azole resistance.农业杀菌剂对病原性酵母菌的附带后果:解决唑类耐药性的一种大健康视角。
Mycoses. 2022 Mar;65(3):303-311. doi: 10.1111/myc.13404. Epub 2021 Dec 3.
5
No Impact of Fluconazole to Echinocandins Replacement as First-Line Therapy on the Epidemiology of Yeast Fungemia (Hospital-Driven Active Surveillance, 2004-2017, Paris, France).氟康唑替换棘白菌素作为一线治疗对酵母血症流行病学的影响(医院主动监测,2004 - 2017年,法国巴黎)。
Front Med (Lausanne). 2021 Apr 20;8:641965. doi: 10.3389/fmed.2021.641965. eCollection 2021.
6
Prenylated -Cinnamic Esters and Ethers against Clinical spp.: Repositioning of Natural Compounds in Antimicrobial Discovery.烯丙基肉桂酸酯和醚类化合物对临床 spp. 的抑制作用:天然化合物在抗菌药物发现中的再定位。
Molecules. 2021 Jan 27;26(3):658. doi: 10.3390/molecules26030658.
7
In Vitro or In Vivo Models, the Next Frontier for Unraveling Interactions between spp. and Hosts. How Much Do We Know?体外或体内模型,揭示物种与宿主间相互作用的新前沿。我们了解多少?
J Fungi (Basel). 2020 Aug 28;6(3):155. doi: 10.3390/jof6030155.
8
Identification of Fungal Species and Detection of Azole-Resistance Mutations in the Gene at a South Korean Hospital.在一家韩国医院鉴定真菌物种和检测 基因中的唑类耐药突变。
Yonsei Med J. 2020 Aug;61(8):698-704. doi: 10.3349/ymj.2020.61.8.698.
9
Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine.利用基于 CRISPR 的平台的潜力来推动医院医学领域的发展。
Expert Rev Anti Infect Ther. 2020 Aug;18(8):799-805. doi: 10.1080/14787210.2020.1761333. Epub 2020 May 4.
10
Insights into the interaction of Scedosporium apiospermum, Scedosporium aurantiacum, Scedosporium minutisporum, and Lomentospora prolificans with lung epithelial cells.对伪阿利什霉、桔青霉、微小孢枝孢霉和多育轮枝霉与肺上皮细胞相互作用的见解。
Braz J Microbiol. 2020 Jun;51(2):427-436. doi: 10.1007/s42770-019-00183-2. Epub 2019 Nov 17.